SINGLE AMINO-ACID CHANGES IN THE DNA-POLYMERASE CONFER FOSCARNET RESISTANCE AND SLOW-GROWTH PHENOTYPE, WHILE MUTATIONS IN THE UL97-ENCODED PHOSPHOTRANSFERASE CONFER GANCICLOVIR RESISTANCE IN 3 DOUBLE-RESISTANTHUMAN CYTOMEGALOVIRUS STRAINS RECOVERED FROM PATIENTS WITH AIDS
F. Baldanti et al., SINGLE AMINO-ACID CHANGES IN THE DNA-POLYMERASE CONFER FOSCARNET RESISTANCE AND SLOW-GROWTH PHENOTYPE, WHILE MUTATIONS IN THE UL97-ENCODED PHOSPHOTRANSFERASE CONFER GANCICLOVIR RESISTANCE IN 3 DOUBLE-RESISTANTHUMAN CYTOMEGALOVIRUS STRAINS RECOVERED FROM PATIENTS WITH AIDS, Journal of virology, 70(3), 1996, pp. 1390-1395
Three human cytomegalovirus (HCMV) strains (VR4760, VR4955, and VR5120
) showing double resistance to ganciclovir (GCV) and foscarnet (PFA) w
ere isolated from three patients with AIDS who underwent multiple sequ
ential courses of therapy with GCV and PFA (A. Sarasini, F. Baldanti,
M. Furione, E. Percivalle, R. Brerra, M. Barbi, and G. Gerna, J. Med.
Virol,, 47:237-244, 1995). We previously demonstrated that the three s
trains were genetically unrelated and that each of them was present as
a single viral population in vivo, Thus, in each of the three cases,
a single viral strain was resistant to both GCV and PFA. In the presen
t paper, we report the characterization of the molecular bases of the
double resistance and demonstrate that the PFA resistance is associate
d with a slower replication of HCMV strains in cell cultures. Sequenci
ng of the UL97 and UL54 genes, GCV anabolism assays, and marker transf
er experiments showed that GCV resistance was due to single amino acid
changes in the UL97 gene product (VR4760, Met-460-->Ile; VR4955, Ala-
594-->Val; VR5120, Leu595-->Ser), while single amino acid changes in d
omain II of the DNA polymerase (VR4760 and VR5120, Val-715-->Met; VR49
55, Thr-700-->Ala) were responsible for both the PFA resistance and th
e slow-growth phenotype, Thus, in these three cases, double resistance
to GCV and PFA was not due to a single mutation conferring cross-resi
stance or to the presence of a mixture of strains with different drug
susceptibilities. The HCMV DNA polymerase recombinant strains carrying
the mutations conferring PFA resistance were sensitive to GCV and S)-
1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC). In addition,
the same UL54 mutations were responsible for the slow growth of the cl
inical isolates, since the recombinant strains showed a marked delay i
n immediate-early antigen plaque formation and a reduction of infectio
us virus yield compared with AD169, from which they were derived, Thes
e results may have some important implications for the successful isol
ation, propagation, and characterization of PFA-resistant strains from
clinical samples containing mixed viral populations.